<unk>  is a corticosteroid primarily used in dermatology to reduce skin inflammation and relieve itching. It is a synthetic hydrocortisone derivative. The fluorine substitution at position 9 in the steroid nucleus greatly enhances its activity. It was first synthesized in 1959 in the Research Department of Syntex Laboratories S.A. Mexico City. Preparations containing it were first marketed under the name Synalar. A typical dosage strength used in dermatology is 0.01–0.025%. One such cream is sold under the brand name Flucort-N and includes the antibiotic neomycin.<unk>  was also found to strongly potentiate TGF-β-associated chondrogenesis of bone marrow mesenchymal stem/progenitor cells, by increasing the levels of collagen type II by more than 100 fold compared to the widely used dexamethasone.<unk>  intravitreal implants have been used to treat non-infectious uveitis. A systematic review could not determine whether<unk>  implants are superior to standard of care treatment for uveitis. A<unk>  intravitreal implant with the brand name Iluvien is sold by biopharmaceutical company Alimera Sciences to treat diabetic macular edema (DME). It was approved for medical use in 1961.
Fluocinolone acetonide
Fluocinonide
Amcinonide
Ciclesonide
Triamcinolone acetonide
Triamcinolone benetonide
Triamcinolone
Stenbolone acetate